CASE REPORT
Misdiagnosis of a chin abscess in a teenager with rhabdomyosarcoma – consequences for the patient’s health and quality of life
More details
Hide details
1
The English Division Pediatric Oncology Scientific Circle, Medical University of Gdansk, Gdansk, Poland
2
Department of Paediatrics, Haematology, and Oncology, Medical University of Gdansk, Gdansk, Poland
Submission date: 2020-04-28
Final revision date: 2020-05-20
Acceptance date: 2020-05-20
Publication date: 2020-07-10
Pediatr Pol 2020;95(2):132-136
KEYWORDS
TOPICS
ABSTRACT
Childhood rhabdomyosarcoma (RMS) develops frequently within head and neck (H&N) structures. Its clinical manifestation may mimic more common benign, inflammatory, and congenital lesions.
A 16-year-old boy with painless purple swelling of the chin soft tissues was treated with local and systemic antibiotics. Because no improvement was achieved, the growing “abscess” was incised and drained many times in the surgical department. After three months of ineffective therapies, the patient was transferred to the clinical hospital, where a tumour infiltrating the chin and oral cavity floor, impairing speech and swallowing, was detected. Alveolar RMS was diagnosed by histopathology of the tumour biopsy. Due to unfavourable prognostic factors, the patient was classified to a very high-risk group and received aggressive long-lasting oncological treatment. Although he achieved full remission, the sequelae of therapy affect his quality of life.
Despite its rarity, RMS should be included in the differential diagnosis of H&N lesions, especially painless and rapidly growing.
REFERENCES (19)
1.
Ray A, Huh WW. Current state-of-the-art systemic therapy for pediatric soft tissue sarcomas. Curr Oncol Rep 2012; 14: 311-319.
2.
Radzikowska J, Kukwa W, Kukwa A, et al. Management of pediatric head and neck rhabdomyosarcoma: A case-series of 36 patients. Oncol Lett 2016; 12: 3555-3562.
3.
Fletcher CDM, Bridge JA, Hogendoorn P, et al. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. 2013.
4.
Perez EA, Kassira N, Cheung MC, et al. Rhabdomyosarcoma in children: A SEER population based study. J Surg Res 2011; 170: e243-251.
5.
Scheer M, Dantonello T, Brossart P, et al. Importance of whole-body imaging with complete coverage of hands and feet in alveolar rhabdomyosarcoma staging. Pediatr Radiol 2018; 48: 648-657.
6.
Williamson D, Missiaglia E, De Reyniès A, et al. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol 2010; 28: 2151-2158.
7.
Dasgupta R, Fuchs J, Rodeberg D. Rhabdomyosarcoma. Semin Pediatr Surg 2016; 25: 276-283.
8.
Turner JH, Richmon JD. Head and neck rhabdomyosarcoma: A critical analysis of population-based incidence and survival data. Otolaryngol Head Neck Surg 2011; 145: 967-973.
9.
Oberlin O, Rey A, Anderson J, et al. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment - results of an international workshop. J Clin Oncol 2001; 19: 197-204.
10.
Radzikowska J, Kukwa W, Kukwa A, et al. Rhabdomyosarcoma of the head and neck in children. Contemp Oncol 2015; 19: 98-107.
11.
Iatrou I, Theologie-Lygidakis N, Schoinohoriti O, et al. Rhabdomyosarcoma of the maxillofacial region in children and adolescents: Report of 9 cases and literature review. J Cranio-Maxillo-Facial Surg 2017; 45: 831-838.
12.
Reilly BK, Kim A, Peńa MT, et al.; Rhabdomyosarcoma of the head and neck in children: Review and update. Int J Pediatr Otorhinolaryngol 2015; 79: 1477-1483.
13.
Pratt CB, Smith JW, Woerner S, et al. Factors leading to delay in the diagnosis and affecting survival of children with head and neck rhabdomyosarcoma. Pediatrics 1978; 61: 30-36.
14.
Häußler SM, Stromberger C, Olze H, et al. Head and neck rhabdomyosarcoma in children: a 20-year retrospective study at a tertiary referral center. J Cancer Res Clin Oncol 2018; 144: 371-379.
15.
Affinita MC, Ferrari A, Milano GM, et al. Long-term results in children with head and neck rhabdomyosarcoma: A report from the Italian Soft Tissue Sarcoma Committee. Pediatr Blood Cancer 2018; 65: e26876.
16.
Merks JHM, de Salvo GL, Bergeron C, et al. Parameningeal rhabdomyosarcoma in pediatric age: Results of a pooled analysis from North American and European cooperative groups. Ann Oncol 2014; 25: 231-236.
17.
Khanna G, Sato Y, Smith RJ, et al. Causes of facial swelling in pediatric patients: correlation of clinical and radiologic findings. Radiographics 2006; 26: 157-172.
18.
Orbach D, Mosseri V, Gallego S, et al. Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies. Head Neck 2017; 39: 24-31.
19.
Strojan P, Hutcheson KA, Eisbruch A, et al. Treatment of late sequelae after radiotherapy for head and neck cancer. Cancer Treat Rev 2017; 59: 79-92.